Tech Company Financing Transactions

Illumigen Biosciences Funding Round

Illumigen Biosciences, based in Seattle, secured $200 thousand in funding from Pacific Horizon Ventures.

Transaction Overview

Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. West 500
Seattle, WA 98119
USA
Email Address
Overview
Illumigen has assembled a world-class team of scientists, clinicians, and business professionals.
Profile
Illumigen Biosciences LinkedIn Company Profile
Social Media
Illumigen Biosciences Company Twitter Account
Company News
Illumigen Biosciences News
Facebook
Illumigen Biosciences on Facebook
YouTube
Illumigen Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Operating Officer
Charles Magness
  Charles Magness LinkedIn Profile  Charles Magness Twitter Account  Charles Magness News  Charles Magness on Facebook
Chief Scientific Officer
Shawn Iadonato
  Shawn Iadonato LinkedIn Profile  Shawn Iadonato Twitter Account  Shawn Iadonato News  Shawn Iadonato on Facebook
VP - R & D
Christina Scherer
  Christina Scherer LinkedIn Profile  Christina Scherer Twitter Account  Christina Scherer News  Christina Scherer on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2007: Collarity venture capital transaction
Next: 6/30/2007: Sapphire Energy venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary